Microbix Biosystms (MBXBF) Stock Statistics & Valuation Metrics

Microbix Biosystms has a market cap or net worth of $28.34M. The enterprise value is $40.83.

Microbix Biosystms has 136,968,660 shares outstanding. The number of shares has decreased by -2.65% in one year.

Microbix Biosystms’s return on equity (ROE) is -0.08 and return on invested capital (ROIC) is -4.39%.

The current PE Ratio of Microbix Biosystms is ―. Microbix Biosystms’s PEG ratio is 0.10.

In the last 12 months, Microbix Biosystms had revenue of 18.59M and earned -2.25M in profits. Earnings per share was -0.02.

In the last 12 months, operating cash flow was -3.29M and capital expenditures -595.17K, giving a free cash flow of -3.89M billion.

Microbix Biosystms pays an annual dividend of ―, resulting in a dividend yield of ―

Microbix Biosystms upcoming earnings date is Dec 17, 2026, TBA (Confirmed).

Microbix Biosystms as a current ratio of 8.48, with Debt / Equity ratio of 27.69%

In the past 12 months, Microbix Biosystms has paid -55.73K in taxes.

Microbix Biosystms EV to EBITDA ratio is 73.65, with an EV/FCF ratio of -35.94.

Microbix Biosystms has $7.16M in cash and marketable securities with $6.72M in debt, giving a net cash position of $440.07K billion.

Gross margin is 45.90%, with operating margin of -8.48%, and net profit margin of -12.08%.

The average price target for Microbix Biosystms is $0.29, which is 11.43% higher than the current price. The consensus rating is Moderate Buy